{"id":"https://openalex.org/W2064908586","doi":"https://doi.org/10.1021/np50064a016","title":"Anti-Aids Agents, 1. Isolation and Characterization of Four New Tetragalloylquinic Acids as a New Class of HIV Reverse Transcriptase Inhibitors from Tannic Acid","display_name":"Anti-Aids Agents, 1. Isolation and Characterization of Four New Tetragalloylquinic Acids as a New Class of HIV Reverse Transcriptase Inhibitors from Tannic Acid","publication_year":1989,"publication_date":"1989-07-01","ids":{"openalex":"https://openalex.org/W2064908586","doi":"https://doi.org/10.1021/np50064a016","mag":"2064908586","pmid":"https://pubmed.ncbi.nlm.nih.gov/2478667"},"language":"en","primary_location":{"id":"doi:10.1021/np50064a016","doi":"https://doi.org/10.1021/np50064a016","is_oa":false,"landing_page_url":"https://doi.org/10.1021/np50064a016","pdf_url":null,"source":{"id":"https://openalex.org/S166799026","display_name":"Journal of Natural Products","issn_l":"0163-3864","issn":["0163-3864","1520-6025"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Natural Products","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109381505","display_name":"Makoto Nishizawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Makoto Nishizawa","raw_affiliation_strings":["Natural Products Laboratory, School of Pharmacy, University of North Carolina, Chapel Hill 27599"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Natural Products Laboratory, School of Pharmacy, University of North Carolina, Chapel Hill 27599","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113538322","display_name":"Takashi Yamagishi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takashi Yamagishi","raw_affiliation_strings":["University of North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000353728","display_name":"Ginger E. Dutschman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ginger E. Dutschman","raw_affiliation_strings":["University of North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064978721","display_name":"William B. Parker","orcid":"https://orcid.org/0000-0002-7387-939X","observed_orcids":["https://orcid.org/0000-0002-7387-939X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William B. Parker","raw_affiliation_strings":["University of North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109077615","display_name":"Anne J. Bodner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne J. Bodner","raw_affiliation_strings":["Biotech Research Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotech Research Laboratories","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016911812","display_name":"Robert E. Kilkuskie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert E. Kilkuskie","raw_affiliation_strings":["Biotech Research Laboratories"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biotech Research Laboratories","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109916120","display_name":"Yung\u2010Chi Cheng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yung-Chi Cheng","raw_affiliation_strings":["University of North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005512198","display_name":"Kuo\u2010Hsiung Lee","orcid":"https://orcid.org/0000-0002-6562-0070","observed_orcids":["https://orcid.org/0000-0002-6562-0070"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kuo-Hsiung Lee","raw_affiliation_strings":["Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.7291,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.95834161,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"52","issue":"4","first_page":"762","last_page":"768"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.8032000064849854,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13817","display_name":"Tannin, Tannase and Anticancer Activities","score":0.06849999725818634,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.024000000208616257,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-reverse-transcriptase-inhibitors","display_name":"HIV reverse transcriptase inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/tannic-acid","display_name":"tannic acid","score":0.9769999980926514},{"id":"https://openalex.org/keywords/antiviral-agents","display_name":"antiviral agents","score":0.6949999928474426},{"id":"https://openalex.org/keywords/dna-polymerase-inhibition","display_name":"DNA polymerase inhibition","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.6890000104904175},{"id":"https://openalex.org/keywords/natural-product-isolation","display_name":"natural product isolation","score":0.8009999990463257}],"concepts":[{"id":"https://openalex.org/C156719811","wikidata":"https://www.wikidata.org/wiki/Q28774","display_name":"Reverse transcriptase","level":4,"score":0.7953559160232544},{"id":"https://openalex.org/C2781393965","wikidata":"https://www.wikidata.org/wiki/Q427956","display_name":"Tannic acid","level":2,"score":0.7184178829193115},{"id":"https://openalex.org/C2777351918","wikidata":"https://www.wikidata.org/wiki/Q421559","display_name":"Reverse-transcriptase inhibitor","level":5,"score":0.5474976301193237},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5247124433517456},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.5121612548828125},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.46252331137657166},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4398070275783539},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4385097324848175},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42943310737609863},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.424201637506485},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4153411090373993},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4092867374420166},{"id":"https://openalex.org/C49105822","wikidata":"https://www.wikidata.org/wiki/Q176996","display_name":"Polymerase chain reaction","level":3,"score":0.10182565450668335},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005707","descriptor_name":"Gallic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005707","descriptor_name":"Gallic Acid","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D005707","descriptor_name":"Gallic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006678","descriptor_name":"HIV","qualifier_ui":"Q000254","qualifier_name":"growth & development","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011801","descriptor_name":"Quinic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011801","descriptor_name":"Quinic Acid","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D011801","descriptor_name":"Quinic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013634","descriptor_name":"Tannins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019384","descriptor_name":"Nucleic Acid Synthesis Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047348","descriptor_name":"Hydrolyzable Tannins","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/np50064a016","doi":"https://doi.org/10.1021/np50064a016","is_oa":false,"landing_page_url":"https://doi.org/10.1021/np50064a016","pdf_url":null,"source":{"id":"https://openalex.org/S166799026","display_name":"Journal of Natural Products","issn_l":"0163-3864","issn":["0163-3864","1520-6025"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Natural Products","raw_type":"journal-article"},{"id":"pmid:2478667","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2478667","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of natural products","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1168760148","display_name":"PHARMACOLOGIC DISPOSITION OF POTENTIAL ANTI-AIDS AGENTS","funder_award_id":"U01AI025697","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W129906525","https://openalex.org/W2042087633","https://openalex.org/W2024873380","https://openalex.org/W2081443138","https://openalex.org/W2067024262","https://openalex.org/W2286752414","https://openalex.org/W1995352622","https://openalex.org/W1559705409","https://openalex.org/W2621512597","https://openalex.org/W2170737518"],"abstract_inverted_index":{"Four":[0],"new":[1,24],"tetragalloylquinic":[2],"acids,":[3],"3,5-di-O-galloyl-4-O-digalloylquinic":[4],"acid,":[5,7,9,12],"3,4-di-O-galloyl-5-O-digalloylquinic":[6],"3-O-digalloyl-4,5-di-O-galloylquinic":[8],"and":[10,15,38,46,51,54,92,108],"1,3,4,5-tetra-O-galloylquinic":[11],"were":[13],"isolated":[14],"characterized":[16],"from":[17],"a":[18,23],"commercial":[19],"tannic":[20],"acid":[21],"as":[22],"class":[25],"of":[26,72,86,115,126],"human":[27],"immunodeficiency":[28],"virus":[29],"(HIV)":[30],"reverse":[31],"transcriptase":[32],"(RT)":[33],"inhibitor.":[34],"Compounds":[35,60],"2,":[36],"3,":[37],"4":[39],"inhibit":[40,63],"HIV":[41,65,81,103,136],"RT":[42,104],"activity":[43],"90,":[44],"89,":[45],"84%":[47],"at":[48,56,77,89,105],"100":[49],"microM":[50,91,94,107],"73,":[52],"70,":[53],"63%":[55],"30":[57,106],"microM,":[58,110],"respectively.":[59,111],"2-5":[61],"also":[62],"the":[64,70,102,122],"growth":[66,83],"in":[67,69],"cells":[68],"range":[71],"61-70%":[73],"with":[74,135],"low":[75],"cytotoxicity":[76],"25":[78,90],"microM.":[79],"The":[80,112],"cell":[82],"inhibitory":[84,113],"effects":[85,100],"these":[87],"compounds":[88],"6.25":[93],"(44-57%)":[95],"are":[96],"comparable":[97],"to":[98],"their":[99],"against":[101,117],"10":[109],"effect":[114],"3":[116,127],"DNA":[118],"polymerases":[119],"indicates":[120],"that":[121],"selective":[123],"antiviral":[124],"action":[125,134],"is":[128],"determined":[129],"by":[130],"more":[131],"than":[132],"its":[133],"RT.":[137]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}